Journal Report

THERAPEUTIC ADVANCES IN DRUG SAFETY

Download PDF
Journal Information
Journal Title
THERAPEUTIC ADVANCES IN DRUG SAFETY
Publisher
SAGE PUBLICATIONS LTD
ISSN
2042-0986
E-ISSN
2042-0994
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Goserelin-triggered immune-mediated rhabdomyolysis in a patient receiving long-term rosuvastatin therapy: A case report
Khashayar Shahverdi, Mahshad Ghoddusi, Zahra Shafizadeh et al.
2026-11 Vol. 17
DOI: 10.1177/20420986261506131
Multisystem adverse drug events of low-dose tirzepatide in a normal - Weight individual: A case report and literature review
Meixia Li, Congkai Zhou, Jinggang Zhou
2026-10 Vol. 17
DOI: 10.1177/20420986261492895
Using a control plan for artificial intelligence and machine learning monitoring within pharmacovigilance
Michael Glaser, Rory Littlebury, Vijay Kara
2026-10 Vol. 17
DOI: 10.1177/20420986261492818
Medication knowledge in psychiatric day hospital patients: The role of polypharmacy
Lina Sophia Queck, Johannes Heck, Olaf Krause et al.
2026-10 Vol. 17
DOI: 10.1177/20420986261496193
Transient monocular vertical hemifield loss as a rare acute oxaliplatin-induced ophthalmological side effect: a case report and review of the literature
Lucie Regaldo-Saint Blancard, Simon Pernot, Marianne Fonck et al.
2026-9 Vol. 17
DOI: 10.1177/20420986261467894
Comparative pharmacovigilance of glycaemic adverse-event reporting for alpelisib and capivasertib: A disproportionality analysis of the FDA adverse event monitoring system
Yongjian Liu, Hao Zhong, Xingjun Huang et al.
2026-9 Vol. 17
DOI: 10.1177/20420986261492821
Risk of <i>Clostridioides difficile</i> infection with potassium-competitive acid blockers: A systematic review with restricted quantitative synthesis
Ah Young Lee, Kwanjoo Lee, Sun Jae Moon et al.
2026-9 Vol. 17
DOI: 10.1177/20420986261492840
Safety-guided selection of CDK4/6 inhibitors in HR+/HER2− metastatic breast cancer: toxicity profiles, dose modification, and clinical risk–benefit considerations
Nidhi Shrivastava, Santosh Laxman Gaonkar, Fayaz Shaik Mahammad
2026-9 Vol. 17
DOI: 10.1177/20420986261454205
Comment on “Machine learning studies of drug-induced nephrotoxicity: A scoping review”. The missing role of causality
Izak A. R. Yasrebi-de Kom, Joanna E. Klopotowska
2026-9 Vol. 17
DOI: 10.1177/20420986261492884
Evaluation of digoxin dosing and therapeutic drug monitoring in adult patients receiving continuous venovenous hemodiafiltration
Madison P. Nordin, Jenna F. Cox, Bryan L. Love et al.
2026-9 Vol. 17
DOI: 10.1177/20420986261481989
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 4, 2026 17:32